GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanHua Bio-medicine Co Ltd (SZSE:000504) » Definitions » Cyclically Adjusted FCF per Share

NanHua Bio-medicine Co (SZSE:000504) Cyclically Adjusted FCF per Share : ¥-0.04 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is NanHua Bio-medicine Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

NanHua Bio-medicine Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.015. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.04 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 27.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of NanHua Bio-medicine Co was 27.30% per year. The lowest was -71.00% per year. And the median was -20.60% per year.

As of today (2024-05-17), NanHua Bio-medicine Co's current stock price is ¥7.27. NanHua Bio-medicine Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥-0.04. NanHua Bio-medicine Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NanHua Bio-medicine Co was 721.00. The lowest was 281.50. And the median was 341.50.


NanHua Bio-medicine Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for NanHua Bio-medicine Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanHua Bio-medicine Co Cyclically Adjusted FCF per Share Chart

NanHua Bio-medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.13 -0.11 -0.06 -0.05

NanHua Bio-medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.05 -0.05 -0.05 -0.04

Competitive Comparison of NanHua Bio-medicine Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, NanHua Bio-medicine Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanHua Bio-medicine Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NanHua Bio-medicine Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NanHua Bio-medicine Co's Cyclically Adjusted Price-to-FCF falls into.



NanHua Bio-medicine Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NanHua Bio-medicine Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.015/115.2271*115.2271
=-0.015

Current CPI (Mar. 2024) = 115.2271.

NanHua Bio-medicine Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.054 98.200 -0.063
201409 -0.008 98.900 -0.009
201412 -0.010 99.000 -0.012
201503 -0.016 99.900 -0.018
201506 -0.018 99.500 -0.021
201509 -0.011 100.500 -0.013
201512 -0.011 100.600 -0.013
201603 -0.027 102.200 -0.030
201606 -0.032 101.400 -0.036
201609 -0.002 102.400 -0.002
201612 0.000 102.600 0.000
201703 -0.013 103.200 -0.015
201706 0.024 103.100 0.027
201709 -0.048 104.100 -0.053
201712 -0.122 104.500 -0.135
201803 -0.040 105.300 -0.044
201806 0.019 104.900 0.021
201809 -0.045 106.600 -0.049
201812 -0.003 106.500 -0.003
201903 -0.028 107.700 -0.030
201906 0.030 107.700 0.032
201909 -0.019 109.800 -0.020
201912 0.057 111.200 0.059
202003 -0.007 112.300 -0.007
202006 0.002 110.400 0.002
202009 -0.019 111.700 -0.020
202012 -0.750 111.500 -0.775
202103 0.007 112.662 0.007
202106 -0.070 111.769 -0.072
202109 0.092 112.215 0.094
202112 0.194 113.108 0.198
202203 -0.012 114.335 -0.012
202206 0.352 114.558 0.354
202209 0.049 115.339 0.049
202212 0.107 115.116 0.107
202303 -0.003 115.116 -0.003
202306 0.026 114.558 0.026
202309 0.018 115.339 0.018
202312 0.053 114.781 0.053
202403 -0.015 115.227 -0.015

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


NanHua Bio-medicine Co  (SZSE:000504) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NanHua Bio-medicine Co was 721.00. The lowest was 281.50. And the median was 341.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


NanHua Bio-medicine Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of NanHua Bio-medicine Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


NanHua Bio-medicine Co (SZSE:000504) Business Description

Traded in Other Exchanges
N/A
Address
13th Floor, South West, Tianxin 3 Choi Building, Changsha, CHN, 410015
NanHua Bio-medicine Co Ltd is engaged in stem cells, immune cells and tissue engineering industry.

NanHua Bio-medicine Co (SZSE:000504) Headlines

No Headlines